Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Vetoquinol SA (Vetoquinol), a subsidiary of Soparfin SCA, is a veterinary pharmaceutical company. It develops, produces, and distributes veterinary drugs and non-medicinal products for cats, dogs, cattle, and pigs. The company offers products in therapy areas which include pain, hygiene and care, dermatology, reproduction, mobility and inflammation, udder health, cardio-nephrology and behaviour management. It also offers diagnostics, digital applications, and services. The company distributes its products under brands such as Tolfedine CS, Clindaseptin, Aurizon, Oridermyl, Longamox, and Pen-Histra-Strep, among others. It offers its products to customers, veterinarians, breeders, and pet owners in Europe, the Americas, Africa, the Middle East, Asia and Oceania. Vetoquinol is headquartered in Lure, France.
Vetoquinol SA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Domains: | Tolfedine CS |
| Mobility, Pain, and Inflammation | Dolpac |
| Dermatology, Hygiene & Care | Zylkene |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Vetoquinol SA | Zoetis Inc | Elanco Animal Health Inc | Virbac SA | Ceva Sante Animale SA |
|---|---|---|---|---|---|
| Headquarters | France | United States of America | United States of America | France | France |
| City | Lure | Parsippany | Indianapolis | Carros | Libourne |
| State/Province | Haute Normandie | New Jersey | Indiana | Provence - Alpes- Cote d'Azur | Aquitaine |
| No. of Employees | 2,497 | 14,500 | 9,400 | 6,442 | 7,000 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Matthieu Frechin | Director; Chief Executive Officer; President | Executive Board | 2023 | 57 |
| Dominique Derveaux | Chief Operating Officer; Director | Executive Board | 2009 | 57 |
| Alain Masson | Director; Pharmacist Manager; Deputy Chief Executive Officer | Executive Board | - | 64 |
| Regis Vimal du Monteil | Chief Financial Officer | Senior Management | - | - |
| Sandrine Perrier | Chief Information Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer